Scholarlink

<p>Heart failure (HF) and malignancy represent two major global health burdens that frequently coexist and lead to poor clinical outcomes. However, the specific impact of malignancy on in-hospital mortality in HF patients remains incompletely understood, and reliable predictive tools specifically for HF patients with comorbid malignancy are currently lacking. This multicenter retrospective study analyzed data from the eICU collaborative research database (eICU database), medical information mart for intensive care IV (MIMIC-IV) databases, and medical information mart for intensive care III (MIMIC-III) databases, including 21,403 HF patients (3341 with malignancy). We employed three analytical approaches: propensity score matching (PSM), inverse probability treatment weighting (IPTW), and multivariable logistic regression to assess malignancy-associated mortality risk. For predictive modeling, five machine learning algorithms were trained on the eICU database (70% training, 30% internal validation) and externally validated using both MIMIC-IV and MIMIC-III datasets. All three analytical methods (PSM, IPTW, and multivariable regression) yielded highly consistent results, demonstrating that malignancy significantly increased in-hospital mortality risk (PSM: OR 1.12, 95% CI 1.00–1.24; IPTW: OR 1.17, 95% CI 1.04–1.31; multivariable regression: OR 1.21, 95% CI 1.08–1.36). The AdaBoost model, developed using 19 key predictive variables selected by the Boruta algorithm, demonstrated excellent performance with a training set AUC of 0.849 and internal validation AUC of 0.740, while maintaining good discriminative ability in external validation (MIMIC-IV: AUC 0.739; MIMIC-III: AUC 0.699). To enhance model interpretability, SHapley additive exPlanations analysis revealed the top five predictive variables: simplified acute physiology score II, mechanical ventilation requirement, heart rate, body temperature, and respiratory rate. For clinical implementation, we developed a web-based calculator (available at:&#xa0;<a href="https://nanzihan1998.shinyapps.io/Mortality/">https://nanzihan1998.shinyapps.io/Mortality/</a>) to facilitate real-time mortality risk assessment. Our analysis suggests malignancy is associated with worse outcomes in HF patients. We developed an interpretable machine learning model that demonstrated moderate predictive performance for in-hospital mortality in this high-risk population.&#xa0;This approach could serve as a foundation for future risk stratification tools, but requires prospective validation before clinical application.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Multicenter machine learning model for assessing the impact of malignancy on in-hospital mortality in heart failure patients: a clinical decision support system with interpretable artificial intelligence

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月20日

查看全文
  • Tao Zhang,
  • Zihan Nan,
  • Shaohan Guo,
  • Shiju Yang,
  • Leying Li,
  • Yifei Zhang,
  • Yan Xin,
  • Zhenjie Hu,
  • Congcong Zhao

摘要

Heart failure (HF) and malignancy represent two major global health burdens that frequently coexist and lead to poor clinical outcomes. However, the specific impact of malignancy on in-hospital mortality in HF patients remains incompletely understood, and reliable predictive tools specifically for HF patients with comorbid malignancy are currently lacking. This multicenter retrospective study analyzed data from the eICU collaborative research database (eICU database), medical information mart for intensive care IV (MIMIC-IV) databases, and medical information mart for intensive care III (MIMIC-III) databases, including 21,403 HF patients (3341 with malignancy). We employed three analytical approaches: propensity score matching (PSM), inverse probability treatment weighting (IPTW), and multivariable logistic regression to assess malignancy-associated mortality risk. For predictive modeling, five machine learning algorithms were trained on the eICU database (70% training, 30% internal validation) and externally validated using both MIMIC-IV and MIMIC-III datasets. All three analytical methods (PSM, IPTW, and multivariable regression) yielded highly consistent results, demonstrating that malignancy significantly increased in-hospital mortality risk (PSM: OR 1.12, 95% CI 1.00–1.24; IPTW: OR 1.17, 95% CI 1.04–1.31; multivariable regression: OR 1.21, 95% CI 1.08–1.36). The AdaBoost model, developed using 19 key predictive variables selected by the Boruta algorithm, demonstrated excellent performance with a training set AUC of 0.849 and internal validation AUC of 0.740, while maintaining good discriminative ability in external validation (MIMIC-IV: AUC 0.739; MIMIC-III: AUC 0.699). To enhance model interpretability, SHapley additive exPlanations analysis revealed the top five predictive variables: simplified acute physiology score II, mechanical ventilation requirement, heart rate, body temperature, and respiratory rate. For clinical implementation, we developed a web-based calculator (available at: https://nanzihan1998.shinyapps.io/Mortality/) to facilitate real-time mortality risk assessment. Our analysis suggests malignancy is associated with worse outcomes in HF patients. We developed an interpretable machine learning model that demonstrated moderate predictive performance for in-hospital mortality in this high-risk population. This approach could serve as a foundation for future risk stratification tools, but requires prospective validation before clinical application.